Home » Medical Devices » Point-Of-Care Diagnostics / Testing (POCT) Market

Point-Of-Care Diagnostics / Testing (POCT) Market

Point-Of-Care Diagnostics / Testing (POCT) Market By Technology (Lateral Flow Assays (LFAs), Dipsticks, Microfluidics/ Lab-on-a-Chip (LOC), Biosensors, Molecular Diagnostics, Immunodiagnostics, Hematology Analyzers, Coagulation Monitoring, Others); By End-User (Hospitals and Clinics, Physician Offices, Ambulatory Care Settings, Home Care, Diagnostic Laboratories, Research Institutes); By Application (Infectious Disease Testing, HIV, Influenza, Hepatitis, Sexually Transmitted Infections (STIs), Others); By Product Type (Blood Glucose Monitoring Kits, Cardiac Marker Testing Kits, Infectious Disease Testing Kits, Pregnancy and Fertility Testing Kits, Hematology Testing Kits, Coagulation Testing Kits, Cholesterol Testing Kits, Urinalysis Testing Kits, Drug-of-Abuse Testing Kits, Others); By Platform (Desktop/ Benchtop Analyzers, Handheld/ Portable Analyzers); By Distribution Channel (Hospitals and Clinics, Pharmacies, Online Retailers, Diagnostic Centers); By Infectious Disease Testing Type (HIV POCT, Influenza POCT, Hepatitis POCT, Sexually Transmitted Infections (STIs), POCT, Others); By Cardiac Marker Testing Type (Troponin Testing, BNP Testing, Others); By Pregnancy and Fertility Testing Type (Pregnancy Testing Kits, Ovulation Prediction Kits); By Quantum Dot Size (Narrow Band QDs, Broad Band QDs); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Point-Of-Care Diagnostics / Testing (POCT) Market Size 2023	USD 45618.5 Million
Point-Of-Care Diagnostics / Testing (POCT) Market, CAGR	11.20%
Point-Of-Care Diagnostics / Testing (POCT) Market Size 2032	USD 118599.8 Million

Market Insights

The global demand for Point-Of-Care Diagnostics / Testing (POCT) was valued at USD 45618.5 Million in 2023 and is expected to reach USD 118599.8 Million in 2032, growing at a CAGR of 11.20% between 2024 and 2032.
Molecular diagnostics is the fastest expanding segment of the Point-of-Care Diagnostics/Testing (POCT) industry, while immunodiagnostics is the dominating category.
In 2021, the Homecare segment had a considerable market share, and hospital and clinics are predicted to grow at the quickest CAGR of 7.8% between 2022 and 2027.
In 2022, the infectious diseases section generated the greatest revenue, accounting for more than 24.4%, while the cancer markers segment is expected to grow by 9.6% throughout the projection year.
The blood glucose monitoring kits segment had the highest revenue share in 2022.
Handheld/portable analyzers are now in high demand.
In 2021, the Homecare & Selfcare Testing category dominated the market, with hospitals and clinics predicted to grow at the quickest CAGR of 7.8% between 2022 and 2027.
HIV POCT has rapidly increased, and another major component is sexually transmitted diseases (STIs) POCT.
BNP testing is a substantial share-holding area.
Pregnancy testing kits are in high demand, and ovulation prediction kits are extremely popular on the market.
North America had the biggest revenue share of more than 43.2% in 2023, while Asia Pacific is predicted to be the fastest-growing geographical market.
The increasing importance of environmental monitoring and public health drives market expansion.
Inaccurate point-of-care diagnostics slows market growth.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Executive Summary

Market Definition

The Point-Of-Care Diagnostics / Testing (POCT) Market is the market for medical devices that employ ultrasound Platform to create images of the internal End-Users of the body. Ultrasound equipment generate high-Distribution Channel sound waves that bounce off tissues and organs, resulting in real-time images that can be utilized for diagnosis. These devices are widely utilized in a variety of medical fields, including obstetrics and gynecology, cardiology, radiology, and others. The ultrasound device market covers the manufacture, distribution, and sale of these equipment to healthcare providers all over the world.

Market Overview

The global Point-Of-Care Diagnostics / Testing (POCT) Markethas witnessed steady growth in recent years and is expected to grow at a CAGR of 11.20% between 2024 and 2032. The market was valued at USD 45618.5 million in 2023 and is expected to reach USD 118599.8 million in 2032.

The POCT market is expanding rapidly around the world. It is propelled by causes such as the rising prevalence of chronic diseases, the need for quick and precise diagnostic results, and the growing desire for decentralized healthcare. POCT has various advantages, including faster turnaround times, more convenience, and the opportunity to conduct testing in non-traditional locations. The market has a wide range of POCT devices and assays, including glucose monitoring, infectious disease testing, cardiac indicators, and pregnancy tests. The market is likely to grow further as technological improvements enable the creation of more innovative and user-friendly POCT devices.

Segmentation by Technology

Molecular Diagnostics is the fastest growing segment of the Point-of-Care Diagnostics/Testing (POCT) market. Molecular diagnostics uses tools that identify and analyze genetic material, such as DNA or RNA, to diagnose and monitor a variety of disorders.
Immunodiagnostics is the dominant segment of the POCT Market.

Segmentation by End-User

In 2021, the Homecare segment enjoyed a significant market share. This is due to the widespread availability of point-of-care devices on over-the-counter (OTC), prescription, and online platforms. Furthermore, at-home point-of-care devices are simple to use and advantageous for patients with diabetes and other serious illnesses such as carpal tunnel syndrome, acute coronary syndrome, and others.
However, hospital & clinics are expected to grow at the fastest CAGR of 7.8% between 2023 and 2032. This is due to an increase in clinic visits by patients suffering from carpal tunnel syndrome, acute coronary syndrome, diabetes, heart disease, and other conditions.

Segmentation by Application

In 2023, the infectious diseases section generated the most revenue, accounting for more than 24.4%. Infectious illness testing has evolved from centralized to decentralized point-of-care testing, resulting in improved patient care.
The cancer markers segment is predicted to expand by 9.6% over the forecast period. Every year, millions of individuals present to the emergency room with signs of a heart attack. Cardiovascular diseases account for around 31% of all deaths.

Segmentation by Product Type

The blood glucose monitoring kits segment had the largest revenue share in 2023. The increased prevalence of diabetes, combined with the need for regular monitoring of blood sugar levels, is driving category expansion.
The fastest-growing segment cardiac marker testing kits. These kits help with the diagnosis and monitoring of cardiovascular disorders that are common around the world.

Segmentation by Platform

Handheld/portable analyzers are now in high demand. These portable analyzers provide convenience and flexibility, allowing healthcare workers to conduct diagnostic tests at the point of service or in remote locations. They are especially beneficial in resource-limited settings or while conducting fieldwork.

Segmentation by Distribution Channel

In 2023, the Homecare & Selfcare Testing category dominated the market. This is due to the widespread availability of point-of-care devices on over-the-counter (OTC), prescription, and online platforms.
However, hospitals and clinics are expected to develop at the fastest CAGR of 7.8% between 2022 and 2027. This is due to an increase in clinic visits by patients suffering from carpal tunnel syndrome, acute coronary syndrome, diabetes, heart disease, and other conditions.

Segmentation by Infectious Disease Testing Type

HIV POCT has grown significantly due to the global effect of HIV/AIDS and the significance of early identification and surveillance.
Another important section is sexually transmitted infections (STIs) POCT, which continues to be a major public health concern around the world.

Segmentation by Cardiac Marker Testing Type

Troponin is a cardiac marker used to identify and track heart problems, including myocardial infarction (heart attack). Troponin testing enables healthcare providers to identify heart damage and make informed treatment decisions.
BNP testing is also a significant share holding segment.

Segmentation by Pregnancy and Fertility Testing Type

Pregnancy testing kits are in increased demand. Individuals often utilize pregnancy testing kits to discover whether or not they are pregnant. They offer a quick and easy approach to confirm pregnancy in the comfort of one’s own home.
Ovulation prediction kits are very popular in the market.

Segmentation by Region

North America had the highest revenue share of more than 43.2% in 2023
Asia Pacific is expected to be the fastest-growing geographical market
The rest of the world, including Latin America, the Middle East, and Africa, supplies the remaining demand for Point-Of-Care Diagnostics / Testing (POCT).

North America had the highest revenue share in 2023. The region will maintain its dominant position during the projection years, owing to the rapidly increasing COVID-19 cases and the presence of important players in the United States and Canada. For example, in March 2022, bioLytical Laboratories Inc., a Canadian company, received CE marking for the iStatis COVID-19 Antigen Home Test. This allows the company to enter the European market.

Asia Pacific is expected to be the fastest-growing geographical market, with a CAGR of 8.1% between 2023 and 2030. The Asia Pacific point-of-care market is likely to be driven by a growing pool of local diagnostic kits and reagents producers that will offer a diverse variety of testing options for coronavirus infection. Countries are constantly expanding their capacities to increase COVID-19 testing. For example, in April 2020, Malaysia’s Ministry of Health approved the use of antigen quick testing kits exported from South Korea to enhance the country’s COVID-19 testing capacity to 16,500 per day.

Key Highlights of the Report

The global Point-Of-Care Diagnostics / Testing (POCT) Market is segmented by Technology, End-User, Applications, Product Type, Platform, Distribution Channel, Infectious Disease Testing Type, Fire Rating and region. The blood glucose monitoring kits segment had the highest revenue share in 2023, while the Homecare & Selfcare Testing category led the market. Additionally, HIV POCT has increased dramatically, and handheld/portable analyzers are in high demand. Also, ovulation prediction kits are extremely popular in the market, with North America leading the market growth.

The market is being driven by increasing need for rapid and accurate diagnostic results, the rising prevalence of chronic diseases and the need for early detection, and technological advancements that will result in more portable and user-friendly POCT devices. Furthermore, regulatory constraints and strict clearance processes, limited reimbursement policies for POCT tests, and reliance on qualified healthcare professionals for correct testing and interpretation are the major restraints of the market.

Nonetheless, North America has the biggest revenue share in 2023. The region will maintain its leading position during the projection period. Furthermore, Asia Pacific is projected to be the fastest-growing geographical market, with a CAGR of 8.1% between 2023 and 2032.

What Are The Main Drivers Of The Global Point-Of-Care Diagnostics / Testing (POCT)Market?

Several reasons drive the Point-of-Care Diagnostics/Testing (POCT) market. There is a growing desire for speedy and precise diagnostic outcomes. Patients and healthcare providers alike want speedy and trustworthy test results to make informed treatment decisions. Furthermore, with the increasing prevalence of chronic diseases, early detection is critical for optimal care. POCT allows healthcare practitioners to diagnose illnesses quickly, which leads to better patient outcomes.

What Are The Major Challenges Faced By The Global Point-Of-Care Diagnostics / Testing (POCT)Market?

While the POCT market is expanding, it is not without its challenges. Regulatory hurdles and complex licensing processes may impede the deployment of novel POCT devices and tests. Compliance with regulatory regulations is critical for maintaining patient safety and test accuracy. Furthermore, limiting reimbursement rules for POCT tests may impede market growth. To encourage the use of POCT, healthcare institutions and insurance providers must provide robust reimbursement structures.

What Are The Growth Opportunities In The Global Point-Of-Care Diagnostics / Testing (POCT)Market?

The POCT market offers numerous promising potential for expansion and innovation. Emerging markets with expanding healthcare infrastructure present considerable opportunities for market growth. These regions can benefit from POCT equipment’ accessibility and End-User, which allows for efficient and rapid diagnosis. Furthermore, the integration of POCT with digital health platforms and telemedicine services creates new opportunities for remote patient monitoring and decentralized healthcare. This integration can improve access to healthcare, particularly in poor areas.

Market Drivers

The global Point-Of-Care Diagnostics / Testing (POCT) Marketis driven by several factors. The following are the key drivers of the global Point-Of-Care Diagnostics / Testing (POCT) Market:

Growing Importance in Environmental Monitoring and Public Health

The increasing importance of point-of-care diagnostics in environmental monitoring and public health needs the development of technologies that simplify networking, making it easier for medical practitioners to interpret test results correctly. For instance, in March 2022, Everything Genetic received authorization from the applicable regulatory agencies in the United Kingdom (UK) to commercialize COVID-19 Antigen Tests in the UK market. The company manufactures lateral flow devices at a single kit price of GBP 2, which is expected to drive growth in the point-of-care diagnostics industry.

Market Restraints

The global Point-Of-Care Diagnostics / Testing (POCT) Marketfaces some challenges that may hinder its growth. These include the following:

Inaccurate Point-Of-Care Diagnostics

The expensive cost of virus-clearing technologies has hampered the widespread inaccuracy of quick point-of-care diagnostic testing, resulting in fewer FDA approvals for rapid tests and a smaller market. Pre-analytical errors are extremely common in point-of-care testing. As a result, such accidents may impede the introduction of new items, limiting market expansion. For example, Siemens Healthcare issued a Class 2 Instrument Recall for its BGEM Analyze Card In-vitro Diagnostic Device, which quantitatively evaluates unanticoagulated arterial, venous, or capillary whole blood in the laboratory or at the point of care. This occurred as a result of contradicting glucose findings on card lot 01-20095-10. These reasons may limit the expansion of the point-of-care diagnostics industry.

Opportunities

The global Point-Of-Care Diagnostics / Testing (POCT) Marketoffers significant growth opportunities. These include the following:

Implementation of Remote Patient Monitoring

The deployment of digital Platform is expected to have a substantial impact on the development of point-of-care solutions in settings with limited resources. As part of their go-to-market strategy, organizations in the POCT field should prioritize the expanding use of telehealth as the industry standard. According to data collected by the Centres for Disease Control and Prevention during the pandemic, approximately 95% of health centres in the United States provided some type of telehealth to their patients. As a result, the emergence of remote patient monitoring systems like PixCell Medical, a point-of-care solution for CBC testing, is expected to have a beneficial impact on market development.

Competitive Landscape

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Players

The global Point-Of-Care Diagnostics / Testing (POCT) Marketis highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

Abbott (U.S.)
F. Hoffmann-La Roche Ltd (Switzerland)
B.D. (U.S.)
Siemens Healthcare Private Limited (Germany)
Bio-Rad Laboratories, Inc. (U.S.)
Danaher (U.S.)
Sekisui Diagnostics (U.S.)
Trinity Biotech (Ireland)
bioMérieux (France)
EKF Diagnostics (Germany)
AccuBioTech Co., Ltd. (China)
Instrumentation Laboratory (U.S.)
Beckman Coulter, Inc. (U.S.)
PTS Diagnostics (U.S.)
Nova Biomedical (U.S.)
Chembio Diagnostics, Inc. (U.S.)
Quidel Corporation (U.S.)
Sienco, Inc (U.S.)

These organizations prioritize product innovation, Point-Of-Care Diagnostics / Testing (POCT) Centers expansion, and mergers and acquisitions to stay competitive.

The global Point-Of-Care Diagnostics / Testing (POCT) Market’s key players continually seek to stay ahead by offering new products and developments.

June 2022, Roche introduces the VENTANA DP 600 slide scanner for digital pathology, which improves patient care through precise diagnosis.

June 2022, Roche introduces a human papillomavirus (HPV) self-sampling tool, expanding cervical cancer screening choices.

May 2022, QIAGEN introduces therascreen EGFR Plus RGQ PCR Kit, which includes C797S detection to help guide non-small cell lung cancer (NSCLC) treatment.

June 2022, BD collaborates with the Mayo Clinic Platform, using real-world clinical data to improve post-market device surveillance and drive patient care innovation.

In June 2021, Quest Diagnostics completes its acquisition of Mercy Laboratory Services. The transaction aims to increase access to innovative, high-quality, and cost-effective laboratory services in the Midwest, allowing for more inexpensive patient care. The acquisition instantly increases Quest’s access to clinicians and patients in Arkansas, Kansas, Missouri, and Oklahoma.

Summary of Key Findings

Inaccurate point-of-care diagnostics fuels market expansion.
Market segmented by Technology, End-User, Applications, Product Type, Platform, Distribution Channel, Infectious Disease Testing Type, Cardiac Marker Testing Type, Pregnancy and Fertility Testing Type and region.
Handheld/portable analyzers are now in high demand.
The blood glucose monitoring kits segment had the highest revenue share in 2022.
North America is leading market growth; the market is highly competitive with key players including Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), B.D. (U.S.), Siemens Healthcare Private Limited (Germany). and Others.

Future Outlook

Increasing adoption of POCT devices in home healthcare settings
Technological advancements leading to more accurate and user-friendly devices
Growing demand for rapid diagnostic solutions
Expansion of POCT into emerging markets
Integration of POCT with digital health platforms
Rising focus on preventive and personalized medicine

How CXOs Can Benefit from the Credence Research Point-Of-Care Diagnostics / Testing (POCT) MarketReport

The Credence Research Point-Of-Care Diagnostics / Testing (POCT) MarketReport provides CXOs with a comprehensive overview of the market, including:

Market size and growth forecast: The report provides detailed estimates of the global Point-Of-Care Diagnostics / Testing (POCT) Marketsize, segmented by Technology, End-User, Applications, Product Type, Platform, Distribution Channel, Infectious Disease Testing Type, Cardiac Marker Testing Type, Pregnancy and Fertility Testing Type and region. It also includes forecasts for the market through 2032, based on key trends and drivers.
Market segmentation: The report segments the Point-Of-Care Diagnostics / Testing (POCT) Marketby Technology, End-User, Applications, Product Type, Platform, Distribution Channel, Infectious Disease Testing Type, Cardiac Marker Testing Type, Pregnancy and Fertility Testing Type and region. This segmentation provides CXOs with a granular understanding of the market and the opportunities in each segment.
Competitive landscape: The report profiles the key players in the Point-Of-Care Diagnostics / Testing (POCT) Marketand provides insights into their strategies, product offerings, and financial performance. This information can help CXOs to identify and assess their competition.
Key trends and drivers: The report identifies and analyzes the key trends and drivers that are shaping the Point-Of-Care Diagnostics / Testing (POCT) Market. This information can help CXOs to make informed decisions about their investments and strategies.

CXOs can use the insights from the Credence Research Point-Of-Care Diagnostics / Testing (POCT) MarketReport to:

Identify growth opportunities: The report can help CXOs to identify new growth opportunities in the Point-Of-Care Diagnostics / Testing (POCT) Market. For example, the report can help CXOs discover exciting new areas for growth in the POCT market
Make informed investment decisions: The report can help CXOs to make informed investment decisions about Point-Of-Care Diagnostics / Testing (POCT). For example, the report can provide CXOs with valuable insights on market trends, competitive landscape, and technological advancements in the Point-Of-Care Diagnostics / Testing (POCT) industry.
Develop competitive strategies: The report can help CXOs to develop competitive strategies for their Point-Of-Care Diagnostics / Testing (POCT) businesses. For example, the report can provide CXOs with a comprehensive analysis of the competitive landscape in the Point-Of-Care Diagnostics / Testing (POCT) Market. It can offer insights into the market share of key players, their product portfolios, pricing strategies, and distribution channels.
Track market developments: The report can help CXOs to track market developments and stay ahead of the curve. For example, the report provides insights into the latest trends and innovations in the Point-Of-Care Diagnostics / Testing (POCT) Market.

Overall, the Credence Research Point-Of-Care Diagnostics / Testing (POCT) MarketReport is a valuable resource for CXOs who are looking to gain a deeper understanding of the market and identify opportunities for growth.

Segmentation

By Technology:

Lateral Flow Assays (LFAs)
Dipsticks
Microfluidics/ Lab-on-a-Chip (LOC)
Biosensors
Molecular Diagnostics
Immunodiagnostics
Hematology Analyzers
Coagulation Monitoring
Others

By End-User:

Hospitals and Clinics
Physician Offices
Ambulatory Care Settings
Home Care
Diagnostic Laboratories
Research Institutes

By Application:

Infectious Disease Testing
HIV
Influenza
Hepatitis
Sexually Transmitted Infections (STIs)
Others
Cardiology
Diabetes Monitoring
Coagulation Monitoring
Pregnancy and Fertility Testing
Cancer Markers
Urinalysis
Cholesterol Testing
Others

By Product Type:

Blood Glucose Monitoring Kits
Cardiac Marker Testing Kits
Infectious Disease Testing Kits
Pregnancy and Fertility Testing Kits
Hematology Testing Kits
Coagulation Testing Kits
Cholesterol Testing Kits
Urinalysis Testing Kits
Drug-of-Abuse Testing Kits
Others

By Platform:

Desktop/ Benchtop Analyzers
Handheld/ Portable Analyzers

By Distribution Channel:

Hospitals and Clinics
Pharmacies
Online Retailers
Diagnostic Centers

By Infectious Disease Testing Type:

HIV POCT
Influenza POCT
Hepatitis POCT
Sexually Transmitted Infections (STIs) POCT
Others

By Cardiac Marker Testing Type:

Troponin Testing
BNP Testing
Others

By Pregnancy and Fertility Testing Type:

Pregnancy Testing Kits
Ovulation Prediction Kits

By Region

North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- France
- The U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa

Table of Content

Chapter No. 1 :………. Introduction.. 24

1.1.1. Report Description. 24

Purpose of the Report. 24

USP & Key Offerings. 24

1.1.2. Key Benefits for Stakeholders. 24

1.1.3. Target Audience. 25

1.1.4. Report Scope 25

Chapter No. 2 :………. Executive Summary. 26

2.1. Point-Of-Care Diagnostics Market Snapshot. 26

2.1.1. Global Point-Of-Care Diagnostics Market, 2018 – 2032 (USD Million). 28

Chapter No. 3 :………. Geopolitical Crisis Impact Analysis. 29

3.1. Russia-Ukraine and Israel-Palestine War Impacts. 29

Chapter No. 4 :………. Point-Of-Care Diagnostics Market – Industry Analysis. 30

4.1. Introduction 30

4.2. Market Drivers 31

4.2.1. Driving Factor 1 Analysis. 31

4.2.2. Driving Factor 2 Analysis. 32

4.3. Market Restraints. 33

4.3.1. Restraining Factor Analysis. 33

4.4. Market Opportunities. 34

4.4.1. Market Opportunity Analysis. 34

4.5. Porter’s Five Forces Analysis. 35

Chapter No. 5 :………. Analysis Competitive Landscape. 36

5.1. Company Market Share Analysis – 2023. 36

5.1.1. Global Point-Of-Care Diagnostics Market: Company Market Share, by Volume, 2023. 36

5.1.2. Global Point-Of-Care Diagnostics Market: Company Market Share, by Revenue, 2023. 37

5.1.3. Global Point-Of-Care Diagnostics Market: Top 6 Company Market Share, by Revenue, 2023 37

5.1.4. Global Point-Of-Care Diagnostics Market: Top 3 Company Market Share, by Revenue, 2023 38

5.2. Global Point-Of-Care Diagnostics Market Company Revenue Market Share, 2023. 39

5.3. Company Assessment Metrics, 2023. 40

5.3.1. Stars 40

5.3.2. Emerging Leaders. 40

5.3.3. Pervasive Players. 40

5.3.4. Participants 40

5.4. Start-ups /SMEs Assessment Metrics, 2023. 40

5.4.1. Progressive Companies. 40

5.4.2. Responsive Companies. 40

5.4.3. Dynamic Companies. 40

5.4.4. Starting Blocks 40

5.5. Strategic Developments. 41

5.5.1. Acquisitions & Mergers. 41

New Product Launch. 41

Global Expansion. 41

5.6. Key Players Product Matrix. 42

Chapter No. 6 :………. PESTEL & Adjacent Market Analysis. 43

6.1. PESTEL 43

6.1.1. Political Factors. 43

6.1.2. Economic Factors. 43

6.1.3. Social Factors 43

6.1.4. Technological Factors. 43

6.1.5. Environmental Factors. 43

6.1.6. Legal Factors 43

6.2. Adjacent Market Analysis. 43

Chapter No. 7 :………. Point-Of-Care Diagnostics Market – By Product Segment Analysis 44

7.1. Point-Of-Care Diagnostics Market Overview, by Product Segment. 44

7.1.1. Point-Of-Care Diagnostics Market Revenue Share, By Product, 2023 & 2032. 45

7.1.2. Point-Of-Care Diagnostics Market Attractiveness Analysis, By Product. 46

7.1.3. Incremental Revenue Growth Opportunity, by Product, 2024 – 2032. 46

7.1.4. Point-Of-Care Diagnostics Market Revenue, By Product, 2018, 2023, 2027 & 2032. 47

7.2. COVID-19 test products. 48

7.3. Glucose Monitoring Products. 49

7.4. Cardiometabolic Monitoring Products. 50

7.5. Infectious Disease Testing Products. 51

7.6. Coagulation Monitoring Products. 52

7.7. Pregnancy & Fertility Testing Products. 53

7.8. Tumor/Cancer Marker Testing Products. 53

7.9. Urinalysis Testing Products. 54

7.10. Cholesterol Testing Products. 54

7.11. Hematology Testing Products. 55

7.12. Thyroid Stimulating Hormone (TSH) Testing Products. 55

7.13. Drugs-of-abuse Testing Products. 56

7.14. Fecal Occult Testing Products. 56

7.15. Other POC Products. 57

Chapter No. 8 :………. Point-Of-Care Diagnostics Market – By Platform Segment Analysis 58

8.1. Point-Of-Care Diagnostics Market Overview, by Platform Segment. 58

8.1.1. Point-Of-Care Diagnostics Market Revenue Share, By Platform, 2023 & 2032. 59

8.1.2. Point-Of-Care Diagnostics Market Attractiveness Analysis, By Platform.. 60

8.1.3. Incremental Revenue Growth Opportunity, by Platform, 2024 – 2032. 60

8.1.4. Point-Of-Care Diagnostics Market Revenue, By Platform, 2018, 2023, 2027 & 2032. 61

8.2. Lateral Flow Assays. 62

8.3. Dipsticks 63

8.4. Microfluidics 64

8.5. Molecular Diagnostics. 65

8.6. Immunoassays 66

Chapter No. 9 :………. Point-Of-Care Diagnostics Market – By Mode of Purchase Segment Analysis. 67

9.1. Point-Of-Care Diagnostics Market Overview, by Mode of Purchase Segment. 67

9.1.1. Point-Of-Care Diagnostics Market Revenue Share, By Mode of Purchase, 2023 & 2032. 68

9.1.2. Point-Of-Care Diagnostics Market Attractiveness Analysis, By Mode of Purchase. 69

9.1.3. Incremental Revenue Growth Opportunity, by Mode of Purchase, 2024 – 2032. 69

9.1.4. Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2018, 2023, 2027 & 2032 70

9.2. Prescription-based Products. 71

9.3. OTC Products 72

Chapter No. 10 :…….. Point-Of-Care Diagnostics Market – By Sample Segment Analysis 73

10.1. Point-Of-Care Diagnostics Market Overview, by Sample Segment. 73

10.1.1. Point-Of-Care Diagnostics Market Revenue Share, By Sample, 2023 & 2032. 74

10.1.2. Point-Of-Care Diagnostics Market Attractiveness Analysis, By Sample. 75

10.1.3. Incremental Revenue Growth Opportunity, by Sample, 2024 – 2032. 75

10.1.4. Point-Of-Care Diagnostics Market Revenue, By Sample, 2018, 2023, 2027 & 2032. 76

10.2. Blood Sample 77

10.3. Urine Sample 78

10.4. Nasal and Oropharyngeal Swabs Sample. 79

10.5. Other Samples 80

Chapter No. 11 :…….. Point-Of-Care Diagnostics Market – By End User Segment Analysis 81

11.1. Point-Of-Care Diagnostics Market Overview, by End User Segment. 81

11.1.1. Point-Of-Care Diagnostics Market Revenue Share, By End-User, 2023 & 2032. 82

11.1.2. Point-Of-Care Diagnostics Market Attractiveness Analysis, By End-User. 83

11.1.3. Incremental Revenue Growth Opportunity, by End-User, 2024 – 2032. 83

11.1.4. Point-Of-Care Diagnostics Market Revenue, By End-User, 2018, 2023, 2027 & 2032. 84

11.2. Clinical Laboratories. 85

11.3. Ambulatory Care Facilities and Physician Offices. 86

11.4. Pharmacies, retail clinics, & E-comm. Platforms. 87

11.5. Home Care & Self Testing. 88

11.6. Other End Users. 89

Chapter No. 12 :…….. Point-Of-Care Diagnostics Market – Global Analysis. 90

12.1. Product 90

12.1.1. Global Point-Of-Care Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 90

12.1.2. Global Point-Of-Care Diagnostics Market Revenue, By Product, 2024 – 2032 (USD Million) 90

12.2. Platform 91

12.2.1. Global Point-Of-Care Diagnostics Market Revenue, By Platform, 2018 – 2023 (USD Million) 91

12.2.2. Global Point-Of-Care Diagnostics Market Revenue, By Platform, 2024 – 2032 (USD Million) 91

12.3. Mode of Purchase. 92

12.3.1. Global Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2018 – 2023 (USD Million) 92

12.3.2. Global Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2024 – 2032 (USD Million) 92

12.4. Sample 93

12.4.1. Global Point-Of-Care Diagnostics Market Revenue, By Sample, 2018 – 2023 (USD Million). 93

12.4.2. Global Point-Of-Care Diagnostics Market Revenue, By Sample, 2024 – 2032 (USD Million). 93

12.5. End-User 94

12.5.1. Global Point-Of-Care Diagnostics Market Revenue, By End-User, 2018 – 2023 (USD Million) 94

12.5.2. Global Point-Of-Care Diagnostics Market Revenue, By End-User, 2024 – 2032 (USD Million) 94

Chapter No. 13 :…….. Point-Of-Care Diagnostics Market – North America.. 95

13.1. North America 95

13.1.1. Key Highlights 95

13.1.2. North America Point-Of-Care Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 96

13.1.3. North America Point-Of-Care Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 97

13.1.4. North America Point-Of-Care Diagnostics Market Revenue, By Platform, 2018 – 2023 (USD Million) 98

13.1.5. North America Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2018 – 2023 (USD Million) 99

13.1.6. North America Point-Of-Care Diagnostics Market Revenue, By Sample, 2018 – 2023 (USD Million) 100

13.1.7. North America Point-Of-Care Diagnostics Market Revenue, By End-User, 2018 – 2023 (USD Million) 101

13.2. U.S. 102

13.3. Canada 102

13.4. Mexico 102

Chapter No. 14 :…….. Point-Of-Care Diagnostics Market – Europe. 103

14.1. Europe 103

14.1.1. Key Highlights 103

14.1.2. Europe Point-Of-Care Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 104

14.1.3. Europe Point-Of-Care Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 105

14.1.4. Europe Point-Of-Care Diagnostics Market Revenue, By Platform, 2018 – 2023 (USD Million) 106

14.1.5. Europe Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2018 – 2023 (USD Million) 107

14.1.6. Europe Point-Of-Care Diagnostics Market Revenue, By Sample, 2018 – 2023 (USD Million) 108

14.1.7. Europe Point-Of-Care Diagnostics Market Revenue, By End-User, 2018 – 2023 (USD Million) 109

14.2. UK 110

14.3. France 110

14.4. Germany 110

14.5. Italy 110

14.6. Spain 110

14.7. Russia 110

14.8. Belgium 110

14.9. Netherland 110

14.10. Austria 110

14.11. Sweden 110

14.12. Poland 110

14.13. Denmark 110

14.14. Switzerland 110

14.15. Rest of Europe 110

Chapter No. 15 :…….. Point-Of-Care Diagnostics Market – Asia Pacific. 111

15.1. Asia Pacific 111

15.1.1. Key Highlights 111

15.1.2. Asia Pacific Point-Of-Care Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 112

15.1.3. Asia Pacific Point-Of-Care Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 113

15.1.4. Asia Pacific Point-Of-Care Diagnostics Market Revenue, By Platform, 2018 – 2023 (USD Million) 114

15.1.5. Asia Pacific Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2018 – 2023 (USD Million) 115

15.1.6. Asia Pacific Point-Of-Care Diagnostics Market Revenue, By Sample, 2018 – 2023 (USD Million) 116

15.1.7. Asia Pacific Point-Of-Care Diagnostics Market Revenue, By End-User, 2018 – 2023 (USD Million) 117

15.2. China 118

15.3. Japan 118

15.4. South Korea 118

15.5. India 118

15.6. Australia 118

15.7. Thailand 118

15.8. Indonesia 118

15.9. Vietnam 118

15.10. Malaysia 118

15.11. Philippines 118

15.12. Taiwan 118

15.13. Rest of Asia Pacific. 118

Chapter No. 16 :…….. Point-Of-Care Diagnostics Market – Latin America. 119

16.1. Latin America 119

16.1.1. Key Highlights 119

16.1.2. Latin America Point-Of-Care Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 120

16.1.3. Latin America Point-Of-Care Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 121

16.1.4. Latin America Point-Of-Care Diagnostics Market Revenue, By Platform, 2018 – 2023 (USD Million) 122

16.1.5. Latin America Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2018 – 2023 (USD Million) 123

16.1.6. Latin America Point-Of-Care Diagnostics Market Revenue, By Sample, 2018 – 2023 (USD Million) 124

16.1.7. Latin America Point-Of-Care Diagnostics Market Revenue, By End-User, 2018 – 2023 (USD Million) 125

16.2. Brazil 126

16.3. Argentina 126

16.4. Peru 126

16.5. Chile 126

16.6. Colombia 126

16.7. Rest of Latin America. 126

Chapter No. 17 :…….. Point-Of-Care Diagnostics Market – Middle East. 127

17.1. Middle East 127

17.1.1. Key Highlights 127

17.1.2. Middle East Point-Of-Care Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 128

17.1.3. Middle East Point-Of-Care Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 129

17.1.4. Middle East Point-Of-Care Diagnostics Market Revenue, By Platform, 2018 – 2023 (USD Million) 130

17.1.5. Middle East Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2018 – 2023 (USD Million) 131

17.1.6. Middle East Point-Of-Care Diagnostics Market Revenue, By Sample, 2018 – 2023 (USD Million) 132

17.1.7. Middle East Point-Of-Care Diagnostics Market Revenue, By End-User, 2018 – 2023 (USD Million) 133

17.2. UAE 134

17.3. KSA 134

17.4. Israel 134

17.5. Turkey 134

17.6. Iran 134

17.7. Rest of Middle East. 134

Chapter No. 18 :…….. Point-Of-Care Diagnostics Market – Africa.. 135

18.1. Africa 135

18.1.1. Key Highlights 135

18.1.2. Africa Point-Of-Care Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million). 136

18.1.3. Africa Point-Of-Care Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million). 137

18.1.4. Africa Point-Of-Care Diagnostics Market Revenue, By Platform, 2018 – 2023 (USD Million) 138

18.1.5. Africa Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2018 – 2023 (USD Million) 139

18.1.6. Africa Point-Of-Care Diagnostics Market Revenue, By Sample, 2018 – 2023 (USD Million). 140

18.1.7. Africa Point-Of-Care Diagnostics Market Revenue, By End-User, 2018 – 2023 (USD Million) 141

18.2. Egypt 142

18.3. Nigeria 142

18.4. Algeria 142

18.5. Morocco 142

18.6. Rest of Africa 142

Chapter No. 19 :…….. Company Profiles. 143

19.1. F. Hoffmann-La Roche Ltd. 143

19.1.1. Company Overview.. 143

19.1.2. Product Portfolio. 143

19.1.3. Swot Analysis 143

19.1.4. Business Strategy. 144

19.1.5. Financial Overview.. 144

19.2. Qiagen 145

19.3. Danaher Corporation. 145

19.4. Becton Dickinson (BD). 145

19.5. bioMérieux 145

19.6. Abbott 145

19.7. Siemens Healthcare GmbH.. 145

19.8. Werfen 145

19.9. Nova Biomedical 145

19.10. Trividia Health, Inc. 145

19.11. QuidelOrtho Corporation. 145

19.12. Trinity Biotech 145

19.13. Sekisui Diagnostics. 145

19.14. Orasure Technologies, Inc. 145

19.15. Spectral Medical, Inc. 145

19.16. EKF Diagnostics Holdings plc. 145

19.17. Anbio Biotechnology Co., Ltd. 145

19.18. AccuBioTech Co., Ltd. 145

19.19. ALPHA LABORATORIES. 145

Chapter No. 20 :…….. Research Methodology. 146

20.1. Research Methodology. 146

20.1.1. Phase I – Secondary Research. 147

20.1.2. Phase II – Data Modeling. 147

Company Share Analysis Model 148

Revenue Based Modeling. 148

20.1.3. Phase III – Primary Research. 149

20.1.4. Research Limitations. 150

Assumptions. 150

List of Figures

FIG NO. 1………. Global Point-Of-Care Diagnostics Market Revenue, 2018 – 2032 (USD Million) 28

FIG NO. 2………. Porter’s Five Forces Analysis for Global Point-Of-Care Diagnostics Market 35

FIG NO. 3………. Company Share Analysis, 2023. 36

FIG NO. 4………. Company Share Analysis, 2023. 37

FIG NO. 5………. Company Share Analysis, 2023. 37

FIG NO. 6………. Company Share Analysis, 2023. 38

FIG NO. 7………. Point-Of-Care Diagnostics Market – Company Revenue Market Share, 2023. 39

FIG NO. 8………. Point-Of-Care Diagnostics Market Revenue Share, By Product, 2023 & 2032. 45

FIG NO. 9………. Market Attractiveness Analysis, By Product 46

FIG NO. 10……… Incremental Revenue Growth Opportunity by Product, 2024 – 2032. 46

FIG NO. 11……… Point-Of-Care Diagnostics Market Revenue, By Product, 2018, 2023, 2027 & 2032. 47

FIG NO. 12……… Global Point-Of-Care Diagnostics Market for COVID-19 test products, Revenue (USD Million) 2018 – 2032 48

FIG NO. 13……… Global Point-Of-Care Diagnostics Market for Glucose Monitoring Products, Revenue (USD Million) 2018 – 2032. 49

FIG NO. 14……… Global Point-Of-Care Diagnostics Market for Cardiometabolic Monitoring Products, Revenue (USD Million) 2018 – 2032. 50

FIG NO. 15……… Global Point-Of-Care Diagnostics Market for Infectious Disease Testing Products, Revenue (USD Million) 2018 – 2032. 51

FIG NO. 16……… Global Point-Of-Care Diagnostics Market for Coagulation Monitoring Products, Revenue (USD Million) 2018 – 2032. 52

FIG NO. 17……… Global Point-Of-Care Diagnostics Market for Pregnancy & Fertility Testing Products, Revenue (USD Million) 2018 – 2032. 53

FIG NO. 18……… Global Point-Of-Care Diagnostics Market for Tumor/Cancer Marker Testing Products, Revenue (USD Million) 2018 – 2032. 53

FIG NO. 19……… Global Point-Of-Care Diagnostics Market for Urinalysis Testing Products, Revenue (USD Million) 2018 – 2032 54

FIG NO. 20……… Global Point-Of-Care Diagnostics Market for Cholesterol Testing Products, Revenue (USD Million) 2018 – 2032 54

FIG NO. 21……… Global Point-Of-Care Diagnostics Market for Hematology Testing Products, Revenue (USD Million) 2018 – 2032. 55

FIG NO. 22……… Global Point-Of-Care Diagnostics Market for Thyroid Stimulating Hormone (TSH) Testing Products, Revenue (USD Million) 2018 – 2032. 55

FIG NO. 23……… Global Point-Of-Care Diagnostics Market for Drugs-of-abuse Testing Products, Revenue (USD Million) 2018 – 2032. 56

FIG NO. 24……… Global Point-Of-Care Diagnostics Market for Fecal Occult Testing Products, Revenue (USD Million) 2018 – 2032. 56

FIG NO. 25……… Global Point-Of-Care Diagnostics Market for Other POC Products, Revenue (USD Million) 2018 – 2032 57

FIG NO. 26……… Point-Of-Care Diagnostics Market Revenue Share, By Platform, 2023 & 2032. 59

FIG NO. 27……… Market Attractiveness Analysis, By Platform.. 60

FIG NO. 28……… Incremental Revenue Growth Opportunity by Platform, 2024 – 2032. 60

FIG NO. 29……… Point-Of-Care Diagnostics Market Revenue, By Platform, 2018, 2023, 2027 & 2032. 61

FIG NO. 30……… Global Point-Of-Care Diagnostics Market for Lateral Flow Assays, Revenue (USD Million) 2018 – 2032 62

FIG NO. 31……… Global Point-Of-Care Diagnostics Market for Dipsticks , Revenue (USD Million) 2018 – 2032. 63

FIG NO. 32……… Global Point-Of-Care Diagnostics Market for Microfluidics, Revenue (USD Million) 2018 – 2032. 64

FIG NO. 33……… Global Point-Of-Care Diagnostics Market for Molecular Diagnostics, Revenue (USD Million) 2018 – 2032 65

FIG NO. 34……… Global Point-Of-Care Diagnostics Market for Immunoassays, Revenue (USD Million) 2018 – 2032 66

FIG NO. 35……… Point-Of-Care Diagnostics Market Revenue Share, By Mode of Purchase, 2023 & 2032. 68

FIG NO. 36……… Market Attractiveness Analysis, By Mode of Purchase. 69

FIG NO. 37……… Incremental Revenue Growth Opportunity by Mode of Purchase, 2024 – 2032. 69

FIG NO. 38……… Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2018, 2023, 2027 & 2032. 70

FIG NO. 39……… Global Point-Of-Care Diagnostics Market for Prescription-based Products, Revenue (USD Million) 2018 – 2032 71

FIG NO. 40……… Global Point-Of-Care Diagnostics Market for OTC Products, Revenue (USD Million) 2018 – 2032 72

FIG NO. 41……… Point-Of-Care Diagnostics Market Revenue Share, By Sample, 2023 & 2032. 74

FIG NO. 42……… Market Attractiveness Analysis, By Sample. 75

FIG NO. 43……… Incremental Revenue Growth Opportunity by Sample, 2024 – 2032. 75

FIG NO. 44……… Point-Of-Care Diagnostics Market Revenue, By Sample, 2018, 2023, 2027 & 2032. 76

FIG NO. 45……… Global Point-Of-Care Diagnostics Market for Blood Sample, Revenue (USD Million) 2018 – 2032 77

FIG NO. 46……… Global Point-Of-Care Diagnostics Market for Urine Sample, Revenue (USD Million) 2018 – 2032 78

FIG NO. 47……… Global Point-Of-Care Diagnostics Market for Nasal and Oropharyngeal Swabs Sample, Revenue (USD Million) 2018 – 2032. 79

FIG NO. 48……… Global Point-Of-Care Diagnostics Market for Other Samples, Revenue (USD Million) 2018 – 2032 80

FIG NO. 49……… Point-Of-Care Diagnostics Market Revenue Share, By End-User, 2023 & 2032. 82

FIG NO. 50……… Market Attractiveness Analysis, By End-User. 83

FIG NO. 51……… Incremental Revenue Growth Opportunity by End-User, 2024 – 2032. 83

FIG NO. 52……… Point-Of-Care Diagnostics Market Revenue, By End-User, 2018, 2023, 2027 & 2032. 84

FIG NO. 53……… Global Point-Of-Care Diagnostics Market for Clinical Laboratories, Revenue (USD Million) 2018 – 2032 85

FIG NO. 54……… Global Point-Of-Care Diagnostics Market for Ambulatory Care Facilities and Physician Offices, Revenue (USD Million) 2018 – 2032. 86

FIG NO. 55……… Global Point-Of-Care Diagnostics Market for Pharmacies, retail clinics, & E-comm. Platforms, Revenue (USD Million) 2018 – 2032. 87

FIG NO. 56……… Global Point-Of-Care Diagnostics Market for Home Care & Self Testing, Revenue (USD Million) 2018 – 2032 88

FIG NO. 57……… Global Point-Of-Care Diagnostics Market for Other End Users, Revenue (USD Million) 2018 – 2032 89

FIG NO. 58……… North America Point-Of-Care Diagnostics Market Revenue, 2018 – 2032 (USD Million) 95

FIG NO. 59……… Europe Point-Of-Care Diagnostics Market Revenue, 2018 – 2032 (USD Million) 103

FIG NO. 60……… Asia Pacific Point-Of-Care Diagnostics Market Revenue, 2018 – 2032 (USD Million) 111

FIG NO. 61……… Latin America Point-Of-Care Diagnostics Market Revenue, 2018 – 2032 (USD Million) 119

FIG NO. 62……… Middle East Point-Of-Care Diagnostics Market Revenue, 2018 – 2032 (USD Million) 127

FIG NO. 63……… Africa Point-Of-Care Diagnostics Market Revenue, 2018 – 2032 (USD Million) 135

FIG NO. 64……… Research Methodology – Detailed View.. 146

FIG NO. 65……… Research Methodology. 147

List of Tables

TABLE NO. 1. :…. Global Point-Of-Care Diagnostics Market: Snapshot 26

TABLE NO. 2. :…. Drivers for the Point-Of-Care Diagnostics Market: Impact Analysis. 31

TABLE NO. 3. :…. Restraints for the Point-Of-Care Diagnostics Market: Impact Analysis. 33

TABLE NO. 4. :…. Global Point-Of-Care Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 90

TABLE NO. 5. :…. Global Point-Of-Care Diagnostics Market Revenue, By Product, 2024 – 2032 (USD Million) 90

TABLE NO. 6. :…. Global Point-Of-Care Diagnostics Market Revenue, By Platform, 2018 – 2023 (USD Million) 91

TABLE NO. 7. :…. Global Point-Of-Care Diagnostics Market Revenue, By Platform, 2024 – 2032 (USD Million) 91

TABLE NO. 8. :…. Global Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2018 – 2023 (USD Million) 92

TABLE NO. 9. :…. Global Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2024 – 2032 (USD Million) 92

TABLE NO. 10. :.. Global Point-Of-Care Diagnostics Market Revenue, By Sample, 2018 – 2023 (USD Million) 93

TABLE NO. 11. :.. Global Point-Of-Care Diagnostics Market Revenue, By Sample, 2024 – 2032 (USD Million) 93

TABLE NO. 12. :.. Global Point-Of-Care Diagnostics Market Revenue, By End-User, 2018 – 2023 (USD Million) 94

TABLE NO. 13. :.. Global Point-Of-Care Diagnostics Market Revenue, By End-User, 2024 – 2032 (USD Million) 94

TABLE NO. 14. :.. North America Point-Of-Care Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 96

TABLE NO. 15. :.. North America Point-Of-Care Diagnostics Market Revenue, By Country, 2024 – 2032 (USD Million) 96

TABLE NO. 16. :.. North America Point-Of-Care Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 97

TABLE NO. 17. :.. North America Point-Of-Care Diagnostics Market Revenue, By Product, 2024 – 2032 (USD Million) 97

TABLE NO. 18. :.. North America Point-Of-Care Diagnostics Market Revenue, By Platform, 2018 – 2023 (USD Million) 98

TABLE NO. 19. :.. North America Point-Of-Care Diagnostics Market Revenue, By Platform, 2024 – 2032 (USD Million) 98

TABLE NO. 20. :.. North America Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2018 – 2023 (USD Million) 99

TABLE NO. 21. :.. North America Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2024 – 2032 (USD Million) 99

TABLE NO. 22. :.. North America Point-Of-Care Diagnostics Market Revenue, By Sample, 2018 – 2023 (USD Million) 100

TABLE NO. 23. :.. North America Point-Of-Care Diagnostics Market Revenue, By Sample, 2024 – 2032 (USD Million) 100

TABLE NO. 24. :.. North America Point-Of-Care Diagnostics Market Revenue, By End-User, 2018 – 2023 (USD Million) 101

TABLE NO. 25. :.. North America Point-Of-Care Diagnostics Market Revenue, By End-User, 2024 – 2032 (USD Million) 101

TABLE NO. 26. :.. Europe Point-Of-Care Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 104

TABLE NO. 27. :.. Europe Point-Of-Care Diagnostics Market Revenue, By Country, 2024 – 2032 (USD Million) 104

TABLE NO. 28. :.. Europe Point-Of-Care Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 105

TABLE NO. 29. :.. Europe Point-Of-Care Diagnostics Market Revenue, By Product, 2024 – 2032 (USD Million) 105

TABLE NO. 30. :.. Europe Point-Of-Care Diagnostics Market Revenue, By Platform, 2018 – 2023 (USD Million) 106

TABLE NO. 31. :.. Europe Point-Of-Care Diagnostics Market Revenue, By Platform, 2024 – 2032 (USD Million) 106

TABLE NO. 32. :.. Europe Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2018 – 2023 (USD Million) 107

TABLE NO. 33. :.. Europe Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2024 – 2032 (USD Million) 107

TABLE NO. 34. :.. Europe Point-Of-Care Diagnostics Market Revenue, By Sample, 2018 – 2023 (USD Million) 108

TABLE NO. 35. :.. Europe Point-Of-Care Diagnostics Market Revenue, By Sample, 2024 – 2032 (USD Million) 108

TABLE NO. 36. :.. Europe Point-Of-Care Diagnostics Market Revenue, By End-User, 2018 – 2023 (USD Million) 109

TABLE NO. 37. :.. Europe Point-Of-Care Diagnostics Market Revenue, By End-User, 2024 – 2032 (USD Million) 109

TABLE NO. 38. :.. Asia Pacific Point-Of-Care Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 112

TABLE NO. 39. :.. Asia Pacific Point-Of-Care Diagnostics Market Revenue, By Country, 2024 – 2032 (USD Million) 112

TABLE NO. 40. :.. Asia Pacific Point-Of-Care Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 113

TABLE NO. 41. :.. Asia Pacific Point-Of-Care Diagnostics Market Revenue, By Product, 2024 – 2032 (USD Million) 113

TABLE NO. 42. :.. Asia Pacific Point-Of-Care Diagnostics Market Revenue, By Platform, 2018 – 2023 (USD Million) 114

TABLE NO. 43. :.. Asia Pacific Point-Of-Care Diagnostics Market Revenue, By Platform, 2024 – 2032 (USD Million) 114

TABLE NO. 44. :.. Asia Pacific Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2018 – 2023 (USD Million) 115

TABLE NO. 45. :.. Asia Pacific Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2024 – 2032 (USD Million) 115

TABLE NO. 46. :.. Asia Pacific Point-Of-Care Diagnostics Market Revenue, By Sample, 2018 – 2023 (USD Million) 116

TABLE NO. 47. :.. Asia Pacific Point-Of-Care Diagnostics Market Revenue, By Sample, 2024 – 2032 (USD Million) 116

TABLE NO. 48. :.. Asia Pacific Point-Of-Care Diagnostics Market Revenue, By End-User, 2018 – 2023 (USD Million) 117

TABLE NO. 49. :.. Asia Pacific Point-Of-Care Diagnostics Market Revenue, By End-User, 2024 – 2032 (USD Million) 117

TABLE NO. 50. :.. Latin America Point-Of-Care Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 120

TABLE NO. 51. :.. Latin America Point-Of-Care Diagnostics Market Revenue, By Country, 2024 – 2032 (USD Million) 120

TABLE NO. 52. :.. Latin America Point-Of-Care Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 121

TABLE NO. 53. :.. Latin America Point-Of-Care Diagnostics Market Revenue, By Product, 2024 – 2032 (USD Million) 121

TABLE NO. 54. :.. Latin America Point-Of-Care Diagnostics Market Revenue, By Platform, 2018 – 2023 (USD Million) 122

TABLE NO. 55. :.. Latin America Point-Of-Care Diagnostics Market Revenue, By Platform, 2024 – 2032 (USD Million) 122

TABLE NO. 56. :.. Latin America Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2018 – 2023 (USD Million) 123

TABLE NO. 57. :.. Latin America Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2024 – 2032 (USD Million) 123

TABLE NO. 58. :.. Latin America Point-Of-Care Diagnostics Market Revenue, By Sample, 2018 – 2023 (USD Million) 124

TABLE NO. 59. :.. Latin America Point-Of-Care Diagnostics Market Revenue, By Sample, 2024 – 2032 (USD Million) 124

TABLE NO. 60. :.. Latin America Point-Of-Care Diagnostics Market Revenue, By End-User, 2018 – 2023 (USD Million) 125

TABLE NO. 61. :.. Latin America Point-Of-Care Diagnostics Market Revenue, By End-User, 2024 – 2032 (USD Million) 125

TABLE NO. 62. :.. Middle East Point-Of-Care Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 128

TABLE NO. 63. :.. Middle East Point-Of-Care Diagnostics Market Revenue, By Country, 2024 – 2032 (USD Million) 128

TABLE NO. 64. :.. Middle East Point-Of-Care Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 129

TABLE NO. 65. :.. Middle East Point-Of-Care Diagnostics Market Revenue, By Product, 2024 – 2032 (USD Million) 129

TABLE NO. 66. :.. Middle East Point-Of-Care Diagnostics Market Revenue, By Platform, 2018 – 2023 (USD Million) 130

TABLE NO. 67. :.. Middle East Point-Of-Care Diagnostics Market Revenue, By Platform, 2024 – 2032 (USD Million) 130

TABLE NO. 68. :.. Middle East Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2018 – 2023 (USD Million) 131

TABLE NO. 69. :.. Middle East Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2024 – 2032 (USD Million) 131

TABLE NO. 70. :.. Middle East Point-Of-Care Diagnostics Market Revenue, By Sample, 2018 – 2023 (USD Million) 132

TABLE NO. 71. :.. Middle East Point-Of-Care Diagnostics Market Revenue, By Sample, 2024 – 2032 (USD Million) 132

TABLE NO. 72. :.. Middle East Point-Of-Care Diagnostics Market Revenue, By End-User, 2018 – 2023 (USD Million) 133

TABLE NO. 73. :.. Middle East Point-Of-Care Diagnostics Market Revenue, By End-User, 2024 – 2032 (USD Million) 133

TABLE NO. 74. :.. Africa Point-Of-Care Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 136

TABLE NO. 75. :.. Africa Point-Of-Care Diagnostics Market Revenue, By Country, 2024 – 2032 (USD Million) 136

TABLE NO. 76. :.. Africa Point-Of-Care Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 137

TABLE NO. 77. :.. Africa Point-Of-Care Diagnostics Market Revenue, By Product, 2024 – 2032 (USD Million) 137

TABLE NO. 78. :.. Africa Point-Of-Care Diagnostics Market Revenue, By Platform, 2018 – 2023 (USD Million) 138

TABLE NO. 79. :.. Africa Point-Of-Care Diagnostics Market Revenue, By Platform, 2024 – 2032 (USD Million) 138

TABLE NO. 80. :.. Africa Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2018 – 2023 (USD Million) 139

TABLE NO. 81. :.. Africa Point-Of-Care Diagnostics Market Revenue, By Mode of Purchase, 2024 – 2032 (USD Million) 139

TABLE NO. 82. :.. Africa Point-Of-Care Diagnostics Market Revenue, By Sample, 2018 – 2023 (USD Million) 140

TABLE NO. 83. :.. Africa Point-Of-Care Diagnostics Market Revenue, By Sample, 2024 – 2032 (USD Million) 140

TABLE NO. 84. :.. Africa Point-Of-Care Diagnostics Market Revenue, By End-User, 2018 – 2023 (USD Million) 141

TABLE NO. 85. :.. Africa Point-Of-Care Diagnostics Market Revenue, By End-User, 2024 – 2032 (USD Million) 141

What is the current size of the global Point-Of-Care Diagnostics / Testing (POCT) Market?

The global Point-Of-Care Diagnostics / Testing (POCT) Market was valued at USD 45618.5 Million in 2023.

What is the expected growth rate of the Point-Of-Care Diagnostics / Testing (POCT) Market between 2024 and 2032?

The Point-Of-Care Diagnostics / Testing (POCT) Market is expected to grow at a CAGR of 11.20% between 2024 and 2032, reaching USD 118599.8 Million in 2032.

Which segment is leading the market share in terms of Product Type?

The blood glucose monitoring kits segment had the greatest revenue share in 2022.

Which Platform segment governs the demand for Platform?

Handheld and portable analyzers are now in high demand.

Which Technology segment is expected to post the fastest growing during the forecast period?

Immunodiagnostics dominates the Point-of-Care Diagnostics/Testing (POCT) industry

Purchase Options

Single User

$4699

Multi User

$5699

Custom Report

$7699

Let us help you

MIKE, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –